Consensus guidelines and recommendations for the management and response assessment of chimeric antigen receptor T-cell therapy in clinical practice for relapsed and refractory multiple myeloma: a report from the International Myeloma Working Group Immunotherapy Committee

  1. Lin, Y.
  2. Qiu, L.
  3. Usmani, S.
  4. Joo, C.W.
  5. Costa, L.
  6. Derman, B.
  7. Du, J.
  8. Einsele, H.
  9. Fernandez de Larrea, C.
  10. Hajek, R.
  11. Ho, P.J.
  12. Kastritis, E.
  13. Martinez-Lopez, J.
  14. Mateos, M.-V.
  15. Mikhael, J.
  16. Moreau, P.
  17. Nagarajan, C.
  18. Nooka, A.
  19. O'Dwyer, M.
  20. Schjesvold, F.
  21. Sidana, S.
  22. van de Donk, N.W.
  23. Weisel, K.
  24. Zweegman, S.
  25. Raje, N.
  26. Otero, P.R.
  27. Anderson, L.D.
  28. Kumar, S.
  29. Martin, T.
  30. Mostrar todos los/as autores/as +
Revista:
The Lancet Oncology

ISSN: 1474-5488 1470-2045

Año de publicación: 2024

Tipo: Revisión

DOI: 10.1016/S1470-2045(24)00094-9 GOOGLE SCHOLAR